| 25055 | MPNABSO | M. pneumoniae Ab, IgG and IgM (MYCO) | M. pneumoniae, Mycoplasma Serology
| | | 22686 | MISC | Macroamylase, Serum | | | | 22687 | MG | Magnesium | Mg, Serum
| | | 25102 | MGRBCSO | Magnesium, RBC (64612) | Magnesium
| | | 22688 | MG-24H | Magnesium, Urine 24 hr | Urine Magnesium | | | 25040 | MG-RU | Magnesium, Urine Random | Urine Magnesium, Random | | | 25041 | MG-CR | Magnesium/Creatinine Urine Ratio | Magnesium Creatinine ratio | Magnesium and Creatinine give Magnesium/Creatinine ratio | | 22690 | MALARIA | Malaria/Blood Parasite Smears | Plasmodium vivax, Plasmodium malarie, Plasmodium ovale, Plasmodium falciparum, Blood Parasite | | | 23422 | BMANGSO | Manganese, Blood (MNB) | Manganese, B
| | | 22691 | MANGSO | Manganese, Serum (MNS) | Manganese (Mn)
| | | 25188 | MISC | Marfan Syndrome, Next-Gen Sequencing (8789) | Marfan Syndrome, Familial Aortic Aneurysm (FAA), Thoracic Aortic Aneurysm and Dissection (TAAD)
| Marfan, Aneurysm and Related Disorders Next-Gen Sequencing Panel detects mutations in all coding domains and splice junctions of ACTA2, CBS, FBN1, FBN2, MYH11, COL3A1, SLC2A10, SMAD3, TGFBR1 and TGFBR2 genes. | | 26475 | MCCSO | Maternal Cell Contamination, Molecular Analysis, Varies (MATCC) | | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. If this test is ordered in conjunction with CMAP / Chromosomal Microarray, Prenatal, Amniotic Fluid/Chorionic Villus Sampling or CMAPC / Chromosomal Microarray, Autopsy, Products of Conception, or Stillbirth, and no other molecular testing is ordered, test will be changed to PPAP / Parental Sample Prep for Prenatal Microarray Testing, Blood. | | 23243 | AFP-4 | Maternal Serum Screen Quadruple Panel | AFP4, Alpha Fetoprotein-4, AFP-4, Quad Screen | Alpha Fetoprotein, Inhibin A, Estriol, Human Chorionic Gonadotropin | | 22208 | AFP-1 | Maternal Serum Screen Single Test Panel AFP (MSAFP) | AFP (maternal), MSAFP, ALPHA FETOPROTEIN-1, AFP-1, AFP-1 (Single Marker MSS) | | | 26069 | MATGNSO | MaterniT Genome | | Trisomy 21, Trisomy 18, Trisomy 13, Other autosomal aneuploidies, sex chromosome aneuploidies and fetal sex classification. 22q11 deletion, 15q11 deletion, 11q23 deletion, 8q24 deletion, 5p15 deletion, 4p16 deletion, 1p36 deletion syndrome. | | 26017 | NGSAMSO | MayoComplete Acute Myeloid Leukemia, 11-Gene Panel, Varies (NGAML) | FLT3; NPM1; CEPBA; IDH1; IDH2; KRAS; NRAS; TP53; Next generation sequencing of leukemia; Next Gen Sequencing Test; NGS for acute myeloid leukemia evaluation; NGS hematologic malignancies; Somatic mutation detection by next generation sequencing (NGS), hematologic; DNMT3A; KIT; RUNX1; NGAML; Enasidenib therapy; Gilteritinib therapy; Ivosidenib therapy; Next-Gen Sequencing, Acute Myeloid Leukemia (NGAML)
| This test includes next-generation sequencing to evaluate for the following 11 genes: CEBPA, DNMT3A, FLT3, IDH1, IDH2, KIT, KRAS, NPM1, NRAS, RUNX1, and TP53. | | 26465 | NGAMTSO | MayoComplete Acute Myeloid Leukemia, Therapeutic Gene Mutation Panel (FLT3, IDH1, IDH2, TP53), Next-Generation Sequencing, Varies (NGAMT) | NGS Acute Myeloid Leukemia, Therapeutic Gene Mutation Pnl (FLT3, IDH1, IDH2, TP53), Varies (NGAMT); FLT3; IDH1; IDH2; Next gen sequencing of leukemia (AML); Next Gen Sequencing Test; NGS cancer panel, hematologic; NGS hematologic malignancies; Somatic mutation detection by next generation sequencing (NGS), hematologic; TP53; Enasidenib therapy; Midostaurin therapy; Gilteritinib therapy; Ivosidenib therapy; NGS for Acute Myeloid Leukemia evaluation | This test includes next-generation sequencing to evaluate for the following 4 genes: FLT3, IDH1, IDH2, and TP53. | | 26018 | NGSHMSO | MayoComplete Myeloid Neoplasms, Comprehensive OncoHeme Next-Generation Sequencing, Varies (NGSHM) | NGS hematologic malignancies, NGS cancer panel, hematologic, Somatic mutation detection by next generation sequencing (NGS), hematologic, Next gen sequencing of leukemia (AML) and myelodysplasia (MDS), NGS for myeloid neoplasm evaluation (MPN), Next Gen Sequencing Test, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TERT, TET2, TP53, U2AF1, WT1, ZRSR2, ANKRD26, DDX41, ELANE, ETNK1, KDM6A, RAD21, SH2B3, SMC3, STAG2, BCORL1, BRAF, Enasidenib therapy, Gilteritinib therapy, Ivosidenib therapy, Midostaurin therapy, NF1, PPM1D, STAT3, UBA1, Mayo Complete
| This test includes next-generation sequencing to evaluate for the following 47 genes and select intronic regions: ANKRD26, ASXL1, BCOR, BCORL1, BRAF, CALR, CBL, CEBPA, CSF3R, DDX41, DNMT3A, ELANE, ETNK1, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KDM6A, KIT, KRAS, MPL, NF1, NPM1, NRAS, PHF6, PPM1D, PTPN11, RAD21, RUNX1, SETBP1, SH2B3, SF3B1, SMC3, SRSF2, STAG2, STAT3, TERT, TET2, TP53, U2AF1, UBA1, WT1, and ZRSR2.
| | 26460 | MDM2FSO | MDM2 (12q15) Amplification, Well-Differentiated Liposarcoma/Atypical Lipomatous Tumor, FISH, Tissue (MDM2F) | ALT
Carboxypeptidase M (CPM) Lipoma WDL/ALT Osteosarcoma | | | 26577 | ROGMSO | Measles (Rubeola) Ab, IgM and IgG (ROGM) | Measles Virus
Rubeola (Measles) Ab, IgG, IgM, S Rubeola Antibodies, IgG and IgM (Separate Determinations), Serum Rubeola Antibody | Measles (Rubeola) Ab, IgM
Measles (Rubeola) Ab, IgG Measles IgG Antibody Index
| | 22693 | MEASLEI | Measles Immune Status | Rubeola Antibody
| | | 25566 | MSPCRSO | Measles Virus, PCR (VR01713) | Measles, PCR
| | | 22695 | MISC | Meperidine and Normeperidine, Serum (67) | Demerol® | | | 22696 | MISC | Mephenytoin (Mesantoin) and Normephenytoin (68) | Mesantoin®; Nirvanol | Mephenytoin (Mesantoin®) and Normephenytoin | | 22698 | MERCUSO | Mercury, 24 Hour, Urine (HGU) | Hg (Mercury), Mercury (Hg)
Mercury, Urine 24 Hour (HGU) U MERCUSO | | | 22697 | MERC | Mercury, Blood (HG) | Mercury (Hg), Hg (Mercury)
| | | 22699 | MPB | Metabolic Panel, Basic | Chemistry Panel, Basic, Basic Metabolic Panel, BMP
| Bicarbonate, Urea Nitrogen, Total Calcium, Chloride, Creatinine, Glucose, Potassium, Sodium, Anion Gap, and Estimated glomerular filtration rate
| | 22700 | MPC | Metabolic Panel, Comprehensive | Chemistry Panel, Comprehensive, Comprehensive Metabolic Panel, CMP
| Albumin, Alkaline Phosphatase, Alanine Amino Transferase, Aspartate Amino Transferase, Bicarbonate, Urea Nitrogen, Calcium, Chloride, Creatinine, Glucose, Potassium, Sodium, Total Bilirubin, Total Protein, Anion Gap, and Estimated glomerular filtration rate | | 26256 | MHPRPSO | Metamycoplasma hominis, Molecular Detection, PCR, Plasma (MHPRP) | Mycoplasma hominis PCR, Mycoplasma hominis, Metamycoplasma hominis
| | | 26121 | MHRPSO | Metamycoplasma hominis, Molecular Detection, PCR, Varies (MHRP) | Mycoplasma hominis
Metamycoplasma hominis | | | 22873 | MET-RND | Metanephrine Fractionation, Urine Random (U MET) | U MET, Metanephrine, Normetanephrine; Metanephrines/Creatinine Ratio
| Urine Metanephrine, Normetanephrine and Creatinine give a Metanephrine/Creatinine Ratio | | 23191 | METFRSO | Metanephrines, Fractionated, Free, Plasma (PMET) | Fractionated metanephrines +, Free Metanephrine, Metanephrines free, plasma, NMN (Normetanephrines), plasma, Normetanephrine, (NMN), free, Normetanephrines, plasma
| | | 22872 | MET | Metanephrines, Urine 24 Hour (24 MET) | 24 MET, Metanephrine, Normetanephrine; Metanephrine Fractionation
| 24 hour Urine Metanephrine, Normetanephrine and Creatinine | | 25095 | CO-METD | Methadone, Urine, Confirm Only by LCMSMS | Dolophine
| | | 22877 | METH | Methemoglobin | | | | 22878 | MTX | Methotrexate | MTX | | | 22879 | METHSUX | Methsuximide (as Desmethylmethsuximide), serum or plasma (Celontin®) (78) | Celontin®
| Methsuximide (Celontin®) as Desmethylmethsuximide | | 22881 | MMA | Methylmalonic Acid | Methylmalonic acid quantitative - serum, MMA
| | | 22882 | MISC | Methylmalonic Acid, Quantitative, Urine (MMAU) | B12 Deficiency, CblC, Cobalamin Deficiency, Methylmalonate, Methylmalonic Acid (MMA),
MMA (Methylmalonic Acid), Methylmalonic Aciduria
| | | 24901 | RITALSO | Methylphenidate (79) | Ritalin®
| | | 25147 | MPHEND | Methylphenidate and Metabolite, Urine | Ritalin, Concerta, Metadate
| | | 22884 | MEX | Mexiletine (MEX) | Mexitil (Mexiletine)
| | | 26257 | MGMTSO | MGMT Promoter Methylation, Tumor (MGMT) | MGMT Promoter Methyl, T (MGMT)
TI MGMTSO | | | 22886 | MA-RU | Microalbumin, Random Urine (U MA) | U MA, Albumin/Creatinine ratio, Microalbumin-random urine
| Albumin, Creatinine and Albumin/Creatinine Ratio | | 22887 | MA | Microalbumin, Urine, 24HR or Timed Overnight (24 MA) | 24 MA, Albumin/Creatinine ratio, Microalbumin-random urine, Albumin in urine
| Albumin and creatinine | | 26374 | FMINTSO | Mint (Mentha Piperita) IgE (FMINT) | Cross reactive with peppermint and spearmint, Mentha Piperita, Mint (Mentha Piperita) IgE (FMINT) | | | 26630 | AMASO | Mitochondrial Antibodies (M2), Serum (AMA) | AMA (Antimitochondrial Antibodies), Antibodies to Microtubule Associated Protein 2, Antimitochondrial Antibodies, Immunology Profile (AMA), Mitochondrial Antibodies, Serum, Primary biliary cirrhosis
| | | 26469 | MITOPSO | Mitochondrial Full Genome Analysis, Next-Generation Sequencing (NGS), Varies (MITOP) | mtDNA, MELAS, Myoclonic Epilepsy with Ragged Red Fibers, MERRF, Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa, NARP, Leigh syndrome, LHON, Chronic progressive external ophthalmoplegia, CPEO, Pearson syndrome, Next Gen Sequencing Test, Leber's hereditary optic neuropathy, Kearns-Sayre syndrome | For skin biopsy or cultured fibroblast specimens, fibroblast culture testing will be performed at an additional charge. If viable cells are not obtained, the client will be notified. | | 22290 | MIX | Mixing Study | Mixing Study, Factor Identification
| Prothrombin Time, Activated Partial Thromboplastin Time, PT and APTT Mixing Studies | | 26351 | ML1HMSO | MLH1 Hypermethylation Analysis, Tumor (ML1HM) | Hypermethylation
MLH1 Hypermethylation Promoter Hypermethylation MLH1HM
| Slide review; MLH1 Hypermethylation Analysis | | 26427 | BRMLHSO | MLH1 Hypermethylation and BRAF Mutation Analysis, Tumor (BRMLH) | BRAF Mutation, BRAF V600E, Hypermethylation, MLH1 Hypermethylation, Promoter Hypermethylation, MLBRF, Lynch syndrome
| | | 26255 | MOGFSSO | MOG-IgG1 FACS Assay, Serum (MOGFS) | MOG-IgG; MOG; Optic Neuritis Antibody; Transverse Myelitis Antibody; Vision Loss Antibody; ADEM antibody; NMO antibody
| When the results of this assay require further evaluation, the reflex titer test (MOGTS) will be performed at an additional charge. | | 26438 | MOUPSO | Mouse Urine Protein, IgE, Serum (MOUP) | Mouse Urine Protein, IgE, Serum, Common House Mouse Urine Protein, House Mouse Urine Protein, Mouse Urine Protein, Muss pp. Mouse
| | | 23315 | MRSAD | MRSA Detection, PCR | Methicillin Resistant Staph aureus
| | | 24810 | MPSQUSO | Mucopolysaccharides, Quantitative, Random, Urine (MPSQU) | Arylsulfatase B Deficiency, Beta-Galactosidase Deficiency, Beta-Glucoronidase Deficiency, Chondroitin-6-Sulfate, Dermatan Sulfate,
GAGS (Glycosaminoglycans), Galactose-6-Sulfatase Deficiency, Glycosaminoglycans (GAGS), Heparan Sulfate, Hunter Syndrome, Hurler Syndrome,
Hurler/Scheie Syndrome, Iduronate Sulfatase Deficiency, Iduronidase Deficiency, Keratan Sulfate, Maroteaux Lamy Syndrome, Morquio A, Morquio B, MPS, MPS I, MPS II, MPS III, MPS IVA, MPS IVB, MPS VI, MPS VII, Mucopolysaccharides, Multiple Sulfatase Deficiency, Sanfilippo Syndrome, Scheie Syndrome, Sly Syndrome | | | 22890 | MUMPSI | Mumps Immune Status | | | | 22889 | MUMPDSO | Mumps Virus Antibody, IgG and IgM, (MMPGM) | Mumps Serology, Mumps Antibody, Mumps Ab, Diagnostic IgG & IgM (MMPGM)
| | | 25485 | MPPCRSO | Mumps Virus, PCR (VR01714) | | | | 24800 | MUSKSO | MuSK Antibody (MUSK) | Muscle Specific Receptor Tyrosine Kinase
| | | 26575 | MUXF3SO | MUXF3 (Cross-reactive Carbohydrate Determinant), IgE, Serum (MUXF3) | | | | 26306 | MGMRSO | Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum (MGMR) | Acetylcholine Receptor (Muscle AChR) Antibodies, Ach Receptor Ab, AChR (Acetylcholine Receptor), AChR Receptor Blocking Ab, Anti-Skeletal Muscle Antibodies, Binding, Blocking, and Modulating Abs, Blocking Ab, Muscle End-Plate Antibodies, MUSK, MuSK myasthenia, Myasthenia Gravis Antibodies, Myasthenia Gravis, Myoid Antibody, Thymoma
| ACh Receptor (Muscle) Binding Ab MuSK Autoantibody
| | 26307 | MGSYNSO | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum (MGLE) | Acetylcholine Receptor (Muscle AChR) Antibodies, Ach Receptor Ab, AChR (Acetylcholine Receptor), AChR Receptor Blocking Ab, Anti-Skeletal Muscle Antibodies, Binding, Blocking, and Modulating Abs, Blocking Ab, Muscle End-Plate Antibodies, MUSK, MuSK myasthenia, Myasthenia Gravis Antibodies, Myasthenia Gravis, Myoid Antibody, Thymoma, LEMS, LES, Lambert-Eaton Myasthenic syndrome, Lambert Eaton, Lambert-Eaton syndrome, P/Q, Calcium channel antibody
| ACh Receptor (Muscle) Binding Ab P/Q-Type Calcium Channel Ab MuSK Autoabtibody
| | 26346 | CTBBLSO | Mycobacterial Culture, Blood (CTBBL) | Acid-Fast Bacilli (AFB)
AFB (Acid-Fast Bacilli) Bacillus, Acid-Fast Culture, TB (Tuberculosis) MTB (Mycobacterium tuberculosis) Mycobacteria Culture Mycobacterium tuberculosis (MTB) TB (Tuberculosis) TB (Tuberculosis) Culture Tubercle Bacilli: Mycobacterium tuberculosis Tuberculosis (TB) | | | 25475 | MTBRPSO | Mycobacterium tuberculosis Complex, Molecular Detection, PCR (MTBRP) | Acid-Fast Bacilli, AFB, Bacillus-Acid Fast, MTB, Mycobacterium tuberculosis, TB, Tuberculosis, Mycobacterium tuberculosis, Tubercle Bacilli: Mycobacterium tuberculosis,
| | | 23268 | MYCOPSO | Mycophenolic Acid, Sera (MPA) | CellCept, MPA-G (Mycophenolic Acid Glucuronide), Mycophenolate Mofetil, Myfortic
| | | 26584 | RPMPMSO | Mycoplasma (Mycoplasmoides) pneumoniae Macrolide (Azithromycin) Resistance Prediction, Molecular Detection, PCR, Varies (RPMPM) | Mycoplasma pneumoniae, Mycoplasmoides pneumoniae
| | | 26169 | MPRPSO | Mycoplasma (Mycoplasmoides) pneumoniae with Macrolide Resistance Reflex, Molecular Detection, PCR, Varies (MPRP) | Mycoplasma pneumoniae, Mycoplasmoides pneumoniae
| | | 26486 | AMGENSO | Mycoplasma genitalium, Transcription-Mediated Amplification, Urine or Urogenital Swab (AMGEN) | AMGEN
Mycoplasma genitalium Mycoplasmoides genitalium
M gen
| | | 26439 | MYD88SO | MYD88, L265P, Somatic Gene Mutation, DNA Allele-Specific PCR, Varies (MYD88) | MYD88, L265, Somatic Gene Mutation, DNA Allele-Specific PCR, Varies (MYD88), MYD88, L265P, B-cell lymphoma, LPL/WM, Lymphoplasmacytic lymphoma, Waldenstrom's macroglobulinemia | | | 25250 | FMDSSO | Myelodysplastic Syndrome (MDS) FISH (MDSF) | MDS
| | | 22895 | MPO | Myeloperoxidase Antibodies | Myeloperoxidase antibodies
| | | 26298 | MYGLUSO | Myoglobin, Random, Urine (MYGLU) | Myoglobin, Urine
Myoglobin, Random, U (MYGLU) U MYGLUSO | | | 26297 | MYGLSSO | Myoglobin, Serum (MYGLS) | | | | 26228 | FMMPPSO | MyoMarker 3 Plus Profile (FMMPP) | FMMPP
Myositis Panel 3 Plus
Myomarker 3 plus
Myo Marker 3 Plus
Myo 3 Plus
Myositis MyoMarker3 Plus Prof(FMMPP)
| | | 26229 | FMYO3SO | MyoMarker 3 Profile (FMYO3) | FMYO3
Myositis Panel 3
Myomarker 3
Myositis | |
|